UnknownPhase 3NCT04221672

The Effect of Terlipressin on Recovery of Liver Function After Hepatectomy

Studying Acute liver failure

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Shanghai Zhongshan Hospital
Principal Investigator
Hui-Chuan Sun, MD&PhD
Fudan University
Intervention
Terlipressin plus standard care(drug)
Enrollment
86 enrolled
Eligibility
18-75 years · All sexes
Timeline
20192020

Study locations (4)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04221672 on ClinicalTrials.gov

Other trials for Acute liver failure

Additional recruiting or active studies for the same condition.

See all trials for Acute liver failure

← Back to all trials